Under construction – not a live service
Sign in

What researchers published on Psoriatic arthritis

762 papers, newest first.

Showing 20 of 762

  • Not labelled yetTwo-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.Rheumatology and therapy
  • Not labelled yetFoot and ankle involvement is common across the spondyloarthritis spectrum with distinct anatomical and clinical patterns: a post hoc cross-sectional analysis of the ASAS-PerSpA study.Rheumatology international
  • Not labelled yetExtracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study.Frontiers in immunology
  • Not labelled yetImpact of radiographic damage on health-related outcomes across rheumatoid arthritis, psoriatic arthritis, and hand osteoarthritis: a comparative analysis of disease burden.Clinical rheumatology
  • Not labelled yetImplementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study.Journal of drugs in dermatology : JDD
  • Not labelled yetProgression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors.Journal of drugs in dermatology : JDD
  • Not labelled yetBimekizumab in Psoriatic Arthritis: 12-Month Retention, Multidomain Effectiveness, and Impact of Prior Interleukin-17 Inhibition in a Real-World Cohort.Joint bone spine
  • Not labelled yetRisk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Case reportAdult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review.EULAR rheumatology open
  • Case reportPsoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.Cureus
  • Not labelled yetResponse to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al.Annals of the rheumatic diseases
  • Not labelled yetDifficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.Seminars in arthritis and rheumatism
  • Not labelled yetThe development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).Arthritis & rheumatology (Hoboken, N.J.)
  • Not labelled yetIncidence and prevalence of hidradenitis suppurativa across spondyloarthritis-related diseases: cohort study using electronic health records.Frontiers in immunology
  • Not labelled yetReal‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.Annals of the rheumatic diseases
  • Not labelled yetSimplified liquid chromatography-mass spectrometry quantification of adalimumab reveals peptide interference and modestly stronger exposure-response associations than ELISA.Analytica chimica acta
  • Not labelled yetPredictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).Rheumatology (Oxford, England)
  • Meta-analysisEpidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence.Diabetes/metabolism research and reviews
  • Not labelled yetImmunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort.Vaccines
  • Not labelled yetLightweight interpretable support vector machine SERS (LiSVM-SERS) learning framework for serological diagnosis of psoriatic arthritis and biomarker identification.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy